These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 26769968)

  • 41. Alteration of Prion Strain Emergence by Nonhost Factors.
    Holec SAM; Yuan Q; Bartz JC
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein Misfolding Cyclic Amplification of Infectious Prions.
    Moda F
    Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The reconstitution of mammalian prion infectivity de novo.
    Baskakov IV
    FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development.
    Wang Y; Jia L; Xie Y; Cai Z; Liu Z; Shen J; Lu Y; Wang Y; Su S; Ma Y; Xiang M
    Atherosclerosis; 2019 Oct; 289():64-72. PubMed ID: 31479773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prions hijack tunnelling nanotubes for intercellular spread.
    Gousset K; Schiff E; Langevin C; Marijanovic Z; Caputo A; Browman DT; Chenouard N; de Chaumont F; Martino A; Enninga J; Olivo-Marin JC; Männel D; Zurzolo C
    Nat Cell Biol; 2009 Mar; 11(3):328-36. PubMed ID: 19198598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Separate mechanisms act concurrently to shed and release the prion protein from the cell.
    Wik L; Klingeborn M; Willander H; Linne T
    Prion; 2012; 6(5):498-509. PubMed ID: 23093798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions.
    Li Q; Wang F; Xiao X; Kim C; Bohon J; Kiselar J; Safar JG; Ma J; Surewicz WK
    J Biol Chem; 2018 Nov; 293(48):18494-18503. PubMed ID: 30275016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
    Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
    Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.
    Mattei V; Barenco MG; Tasciotti V; Garofalo T; Longo A; Boller K; Löwer J; Misasi R; Montrasio F; Sorice M
    PLoS One; 2009; 4(4):e5057. PubMed ID: 19337375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autophagy pathways in the treatment of prion diseases.
    Abdelaziz DH; Abdulrahman BA; Gilch S; Schatzl HM
    Curr Opin Pharmacol; 2019 Feb; 44():46-52. PubMed ID: 31096117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
    Kourie JI
    Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomes and the Prion Protein: More than One Truth.
    Hartmann A; Muth C; Dabrowski O; Krasemann S; Glatzel M
    Front Neurosci; 2017; 11():194. PubMed ID: 28469550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.
    Hamanaka T; Nishizawa K; Sakasegawa Y; Oguma A; Teruya K; Kurahashi H; Hara H; Sakaguchi S; Doh-Ura K
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.